 |
Welcome, Introduction, and Program Overview
Deborah Brooks, MSN, APRN, BC, CNN-NP
|
 |
Calcification in Kidney Disease
Anjay Rastogi, MD |
 |
New CKD-MBD Options: Individualize the Treatment Plan to your Patient
Kim Alleman, MS, RN, FNP-BC, APRN, CNN-NP |
 |
Panel Discussion
Anjay Rastogi and
Kim Alleman |
At the completion of this activity, the participant should be able to:
 |
Identify strategies for treatment of mineral and bone disorder in patients with CKD |
 |
Perform physical assessment that includes concern for the ability of the patient to participate in various treatment options |
 |
Summarize new developments and future practices related to improving mortality and clinical outcomes in all patients with CKD |
|
Anjay Rastogi MD
Division of Nephrology and Clinical Pharmacology
David Geffen School of Medicine
UCLA
Kim Alleman, MS, APRN, FNP-BC, CNN-NP
Nurse Practitioner
Hartford Hospital Transplant Program
|
|
 |
This activity
has been planned and produced in accordance with
CE guidelines and policies. From a CE symposium
held in April 2009 at the American Nephrology
Nurses' Association (ANNA) National Symposium in San Diego, California.
This activity provides 1.25 contact hours.
The American Nephrology Nurses’ Association (ANNA) is accredited as a provider
of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a Provider approved by the California Board of Registered Nursing, provider number CEP 00910 for 1.25 contact hours.
|
|
Posting Date: September 26, 2009
CE Credit Eligible
Through: September 26, 2011
CE Credit Hours/Completion Time: 1.25
Target Audiences: Nephrology nurses and technicians.
Method of participation: Listen to the talk, read the PubMed
abstracts linked to data slides and talk references, take the post-test, read
the linked abstracts in the post-test answer feedback material. |
 |
SPEAKER DISCLOSURE STATEMENT: |
See individual talks.
This ANNA National symposium was developed by ANNA and sponsored by an educational grant from Genzyme.
ANNA and HDCN CE POLICY
STATEMENTS: |
The CE policy and disclosure statements of the American Nephrology Nurses' Association
are given in detail on the Symposium
Home Page. The CE policy statements of HDCN are
listed on this page. |
|